ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.682,11
0,00%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08265
0,01%
Bitcoin
69.606,91
0,73%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTHD)

  7. Arch Therapeutics Inc (QB) (ARTHD) News

ARTHD

Arch Therapeutics (QB) (ARTHD)

Arch Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ARTHD
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
09/05/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
06/05/202422h36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
03/04/202423h07Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
18/03/202421h29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202422h31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/03/202422h30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
20/02/202423h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
15/02/202422h30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ARTHDArch Therapeutics Inc (QB)
07/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/01/202418h39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
12/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
11/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
29/12/202322h30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:ARTHDArch Therapeutics Inc (QB)
15/12/202322h31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
08/12/202322h34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/11/202322h33Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
15/11/202322h47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
09/11/202312h50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
05/10/202323h27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
04/10/202322h11Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
27/09/202323h12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
13/09/202322h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202323h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
08/09/202323h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
07/09/202322h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
06/09/202322h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
01/09/202322h30Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
23/08/202314h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
22/08/202322h52Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTHD

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
NASDAQ
TSLA
Tesla
USOTC
RHHBY
Roche (QX)
FX
EURGBP
Euro vs Sterling
DBI
DAX
DAX
CCOM
US500
US 500
FX
EURUSD
Euro vs US Dollar
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
TG
TUI1
Tui
PM
XAUUSD
Gold vs US Dollar
DBI
TDXP
Tec DAX
TG
MBG
MercedesBenz
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten